Structural determination of the complement inhibitory domain of Borrelia burgdorferi BBK32 provides insight into classical pathway complement evasion by Lyme disease spirochetes.
Bacterial Proteins
/ genetics
Borrelia burgdorferi
/ genetics
Borrelia burgdorferi Group
Complement C1r
/ metabolism
Complement Pathway, Classical
/ genetics
Complement System Proteins
/ metabolism
Humans
Lyme Disease
/ physiopathology
Protein Domains
/ physiology
Recombinant Proteins
Sequence Analysis, Protein
Journal
PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
19
11
2018
accepted:
26
02
2019
revised:
02
04
2019
pubmed:
22
3
2019
medline:
25
4
2019
entrez:
22
3
2019
Statut:
epublish
Résumé
The carboxy-terminal domain of the BBK32 protein from Borrelia burgdorferi sensu stricto, termed BBK32-C, binds and inhibits the initiating serine protease of the human classical complement pathway, C1r. In this study we investigated the function of BBK32 orthologues of the Lyme-associated Borrelia burgdorferi sensu lato complex, designated BAD16 from B. afzelii strain PGau and BGD19 from B. garinii strain IP90. Our data show that B. afzelii BAD16-C exhibits BBK32-C-like activities in all assays tested, including high-affinity binding to purified C1r protease and C1 complex, and potent inhibition of the classical complement pathway. Recombinant B. garinii BGD19-C also bound C1 and C1r with high-affinity yet exhibited significantly reduced in vitro complement inhibitory activities relative to BBK32-C or BAD16-C. Interestingly, natively produced BGD19 weakly recognized C1r relative to BBK32 and BAD16 and, unlike these proteins, BGD19 did not confer significant protection from serum killing. Site-directed mutagenesis was performed to convert BBK32-C to resemble BGD19-C at three residue positions that are identical between BBK32 and BAD16 but different in BGD19. The resulting chimeric protein was designated BXK32-C and this BBK32-C variant mimicked the properties observed for BGD19-C. To query the disparate complement inhibitory activities of BBK32 orthologues, the crystal structure of BBK32-C was solved to 1.7Å limiting resolution. BBK32-C adopts an anti-parallel four-helix bundle fold with a fifth alpha-helix protruding from the helical core. The structure revealed that the three residues targeted in the BXK32-C chimera are surface-exposed, further supporting their potential relevance in C1r binding and inhibition. Additional binding assays showed that BBK32-C only recognized C1r fragments containing the serine protease domain. The structure-function studies reported here improve our understanding of how BBK32 recognizes and inhibits C1r and provide new insight into complement evasion mechanisms of Lyme-associated spirochetes of the B. burgdorferi sensu lato complex.
Identifiants
pubmed: 30897158
doi: 10.1371/journal.ppat.1007659
pii: PPATHOGENS-D-18-02228
pmc: PMC6445466
doi:
Substances chimiques
Bacterial Proteins
0
Recombinant Proteins
0
p35 antigen, Borrelia
0
Complement System Proteins
9007-36-7
Complement C1r
EC 3.4.21.41
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1007659Subventions
Organisme : NIAID NIH HHS
ID : R21 AI133367
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Clin Microbiol. 2003 Aug;41(8):3905-10
pubmed: 12904415
mBio. 2013 Aug 13;4(4):
pubmed: 23943762
Infect Immun. 2004 Mar;72(3):1580-6
pubmed: 14977964
Infect Immun. 2001 Dec;69(12):7800-9
pubmed: 11705962
Infect Immun. 1998 Mar;66(3):1248-51
pubmed: 9488421
Cell Rep. 2016 Sep 6;16(10):2593-2604
pubmed: 27568563
Mol Microbiol. 2015 Apr;96(1):68-83
pubmed: 25560615
J Biol Chem. 2013 Aug 30;288(35):25229-25243
pubmed: 23861404
Front Immunol. 2016 Sep 26;7:385
pubmed: 27725820
J Immunol. 2003 Mar 15;170(6):3214-22
pubmed: 12626580
J Mol Biol. 2018 Jul 20;430(15):2237-2243
pubmed: 29258817
J Infect Dis. 2010 Aug 15;202(3):490-8
pubmed: 20565259
Front Immunol. 2015 May 26;6:257
pubmed: 26074922
Nature. 1997 Dec 11;390(6660):580-6
pubmed: 9403685
J Infect Dis. 1996 Jul;174(1):97-104
pubmed: 8656020
J Immunol. 2001 Nov 1;167(9):5202-8
pubmed: 11673533
Biochim Biophys Acta. 1980 Nov 6;616(1):116-29
pubmed: 6254570
Mol Microbiol. 2011 Oct;82(1):99-113
pubmed: 21854463
Mol Immunol. 2010 Mar;47(6):1299-305
pubmed: 20022381
Infect Immun. 1993 May;61(5):2192-5
pubmed: 8478109
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13916-20
pubmed: 23922389
Infect Immun. 1997 Apr;65(4):1228-36
pubmed: 9119456
Nat Rev Microbiol. 2012 Jan 09;10(2):87-99
pubmed: 22230951
Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):768-773
pubmed: 29311313
PLoS Pathog. 2016 Jan 25;12(1):e1005404
pubmed: 26808924
J Immunol. 2016 Sep 15;197(6):2051-60
pubmed: 27591336
Cell Microbiol. 2017 Dec;19(12):
pubmed: 28873507
Acta Crystallogr D Biol Crystallogr. 2013 Nov;69(Pt 11):2276-86
pubmed: 24189240
PLoS Pathog. 2013;9(12):e1003816
pubmed: 24348255
Methods Enzymol. 1997;276:307-26
pubmed: 27754618
Nat Rev Microbiol. 2014 Jan;12(1):49-62
pubmed: 24336184
Infect Immun. 2001 Jun;69(6):3685-91
pubmed: 11349031
Infect Immun. 2006 Jan;74(1):435-41
pubmed: 16368999
Infect Genet Evol. 2011 Oct;11(7):1545-63
pubmed: 21843658
J Bacteriol. 2007 Jan;189(2):437-45
pubmed: 17098904
Front Immunol. 2018 May 07;9:959
pubmed: 29867944
Vaccine. 2008 Dec 30;26 Suppl 8:I75-8
pubmed: 19388169
Nat Immunol. 2017 Nov 16;18(12):1288-1298
pubmed: 29144501
Infect Immun. 2003 Jun;71(6):3597-602
pubmed: 12761145
Front Immunol. 2015 Jun 02;6:262
pubmed: 26082779
Methods Mol Biol. 2018;1690:183-200
pubmed: 29032546
Front Immunol. 2017 Feb 20;8:116
pubmed: 28265270
Methods Mol Biol. 2008;426:419-35
pubmed: 18542881
Proc Natl Acad Sci U S A. 2017 Apr 25;114(17):E3490-E3498
pubmed: 28396443
Front Immunol. 2017 May 18;8:571
pubmed: 28572805
Mol Microbiol. 2012 Dec;86(5):1116-31
pubmed: 23095033
Trends Microbiol. 2002 Feb;10(2):74-9
pubmed: 11827808
Infect Immun. 2009 Jan;77(1):300-6
pubmed: 19001079
Protein Expr Purif. 2006 Mar;46(1):23-32
pubmed: 16260150
Front Microbiol. 2017 Jan 31;8:89
pubmed: 28197139
FEMS Immunol Med Microbiol. 2005 Feb 1;43(2):165-72
pubmed: 15681146
Mol Microbiol. 2006 Mar;59(5):1591-601
pubmed: 16468997
Cell Microbiol. 2015 Jun;17(6):860-75
pubmed: 25486989
J Infect Dis. 2004 Apr 15;189(8):1515-23
pubmed: 15073690
JAMA. 2013 Sep 18;310(11):1110
pubmed: 24045727
J Biol Chem. 2014 Aug 8;289(32):22490-9
pubmed: 24962582
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Nat Rev Microbiol. 2008 Feb;6(2):132-42
pubmed: 18197169
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10037-41
pubmed: 11517324
Ticks Tick Borne Dis. 2013 Feb;4(1-2):26-34
pubmed: 23219363
Mol Immunol. 2003 Jan;39(11):655-68
pubmed: 12493641
EMBO J. 2002 Feb 1;21(3):231-9
pubmed: 11823416
J Bacteriol. 1996 Jun;178(12):3508-16
pubmed: 8655548
Biochem J. 1985 Jan 1;225(1):135-42
pubmed: 2983658
Anal Biochem. 2006 Feb 1;349(1):136-47
pubmed: 16337141
Infect Immun. 1995 Apr;63(4):1573-80
pubmed: 7890424
Science. 2016 May 6;352(6286):680-7
pubmed: 27151862
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1948-54
pubmed: 12393927
Infect Immun. 2014 Jun;82(6):2520-31
pubmed: 24686059
J Biol Chem. 2004 Oct 1;279(40):41706-14
pubmed: 15292204
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
J Immunol. 2002 Oct 1;169(7):3847-53
pubmed: 12244181
PLoS One. 2009;4(4):e5412
pubmed: 19404402
Infect Immun. 2003 Jun;71(6):3587-96
pubmed: 12761144
PLoS Pathog. 2018 May 29;14(5):e1007106
pubmed: 29813137
Science. 2018 Feb 16;359(6377):794-797
pubmed: 29449492
Adv Exp Med Biol. 2012;946:113-33
pubmed: 21948365
Mol Microbiol. 2016 Jan;99(2):407-24
pubmed: 26434356
PLoS Pathog. 2015 Jul 02;11(7):e1004976
pubmed: 26136236
PLoS One. 2016 Jul 19;11(7):e0159118
pubmed: 27434228
Bioinformatics. 2011 Feb 1;27(3):343-50
pubmed: 21134891
Mol Microbiol. 1998 Dec;30(5):1003-15
pubmed: 9988477
Infect Immun. 2001 Jun;69(6):4129-33
pubmed: 11349087
Nat Immunol. 2010 Sep;11(9):785-97
pubmed: 20720586
Semin Immunopathol. 2018 Jan;40(1):37-48
pubmed: 28842749
Infect Immun. 2015 Sep;83(9):3693-703
pubmed: 26150534